UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 853

Sortiert nach

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Blood, 2020-10, Vol.136 (15), p.1786-1789

2020

Volltextzugriff (PDF)

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Blood advances, 2020-11, Vol.4 (21), p.5580-5588

2020

Volltextzugriff (PDF)

Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Leukemia, 2022-01, Vol.36 (1), p.257-262

2022

Volltextzugriff (PDF)

Unravelling ALL: The Keys to Improved Post-Transplant Survival in Acute Lymphoblastic Leukemia

Transplantation and cellular therapy, 2022-08, Vol.28 (8), p.415-416

2022

Volltextzugriff (PDF)

Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

Cancer, 2020-05, Vol.126 (10), p.2183-2192

2020

Volltextzugriff (PDF)

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2019-04, Vol.54 (4), p.601-606

2019

Volltextzugriff (PDF)

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1316-1324

2021

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies

AIDS (London), 2016-11, Vol.30 (17), p.2653-2657

2016

Volltextzugriff (PDF)

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Blood, 2016-09, Vol.128 (10), p.1346-1361

2016

Volltextzugriff (PDF)

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

Cancer, 2020-05, Vol.126 (10), p.2193-2205

2020

Volltextzugriff (PDF)

Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS

American journal of hematology, 2023-05, Vol.98 (5), p.712-719

2023

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Bone marrow transplantation (Basingstoke), 2022-01, Vol.57 (1), p.51-56

2022

Volltextzugriff (PDF)

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

Haematologica (Roma), 2022-10, Vol.107 (10), p.2496

2022

Volltextzugriff (PDF)

Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era

British journal of haematology, 2021-06, Vol.193 (5), p.1004-1008

2021

Volltextzugriff (PDF)

Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome

Cancer, 2021-05, Vol.127 (10), p.1598-1605

2021

Volltextzugriff (PDF)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Blood advances, 2021-12, Vol.5 (24), p.5599-5607

2021

Volltextzugriff (PDF)

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

BMC cancer, 2023-12, Vol.23 (1), p.1258-1258, Article 1258

2023

Volltextzugriff (PDF)

Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future

Stem cells translational medicine, 2014-12, Vol.3 (12), p.1435-1443

2014

Volltextzugriff (PDF)

Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study

American journal of hematology, 2024-04, Vol.99 (4), p.562-569

2024

Volltextzugriff (PDF)

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

British journal of haematology, 2016-05, Vol.173 (3), p.444-455

2016

Volltextzugriff (PDF)

1 – 25 von 853

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(676)
Mit Volltextzugriff
(818)

Publikationsform

Sprache

Englisch
(853)
Japanisch
(47)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(316)
Science & Technology
(316)
Humans
(262)
Hematology
(255)
Middle Aged
(187)
Female
(172)
Adult
(169)
Male
(169)
Transplantation
(158)
Aged
(154)
Immunology
(132)
Hematopoietic Stem Cell Transplantation
(105)
Hematology, Oncology And Palliative Medicine
(101)
Retrospective Studies
(91)
Treatment Outcome
(85)
Oncology
(84)
Stem Cell Transplantation
(69)
Transplantation, Homologous
(65)
Adolescent
(63)
Young Adult
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19 + B cell tumors: a phase 1/2 trial

Outcomes in patients with newly diagnosed TP53‐mutated acute myeloid leukemia with or without venetoclax‐based therapy

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation

Unravelling ALL: The Keys to Improved Post-Transplant Survival in Acute Lymphoblastic Leukemia

Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD

Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS

Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era

Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future

Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study

Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

Suchergebnisse filtern